• Profile
Close

Circulating exosomal miR-27a and miR-130a act as novel diagnostic and prognostic biomarkers of colorectal cancer

Cancer Epidemiology, Biomarkers & Prevention May 15, 2018

Wang S, et al. - Whether or not specific circulating exosomal miRNAs could act as biomarkers for early diagnosis of colorectal cancer (CRC) was investigated. Researchers included a total of 369 peripheral blood samples in this study. They selected circulating exosomal miR-27a and miR-130a in the discovery phase after synthetical analysis of two GEO datasets and TCGA database. The exosomal miR-27a and miR-130a panel for the detection of CRC was identified that may act as a non-invasive biomarker for early detection and predicting prognosis of CRC.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay